Companies

Advesya aims to develop and commercialise CAR-T cell therapies

AlloCyte Pharmaceuticals is a Swiss-based biopharmaceutical company.

Anaveon is a clinical stage company committed to transforming immunological insights into life-saving therapies.

ARTIDIS AG, development and commercialization of ARTIDIS (Automated And Reliable Tissue Diagnostics).

Aurealis Therapeutics is a clinical-stage Swiss-Finnish Biotechnology company.

BaseLaunch Accelerator (therapeutics & biotech innovation).

BioVersys switches off bacterial drug resistance, thus reactivating approved antibiotics.

Proactive climate management is crucial for the sustainable development of our planet. ccloop is committed to decoupling raw material streams used in the production of daily life goods from fossil resources (such as oil, gas, and coal). This process is commonly known as defossilisation.

Cellestia is a clinical stage R&D company.

Cimeio is an applied gene editing, cellular, and immunotherapy company.

Di Meliora AG is active in manufacture of medical and dental instruments and supplies.

Edelweiss Connect manages collaborative projects.

FGen is a service provider for biotechnology, life-sciences, and industry.

Towards a Disease Modifying Treatment for Endometriosis.

Targeting fundamentals of inflammation, autoimmunity and fibrosis

Intilaris LifeSciences is a consulting and service company

Our core purpose is to create and develop novel and targeted antibodies to improve the lives of patients with cancer and autoimmune disorders.

MOMM develops high-sensitivity rapid diagnostic tests.

Myria Biosciences pioneers a new class of therapeutic molecules that combine the most important features of small molecules and biologics.

NBE-Therapeutics is focused on the development of novel antibody-based therapeutics.

Ridgeline is a Versant Ventures Discovery Engine.

Skyhawk Therapeutics, is a drug discovery and development company.

Stromal Therapeutics AG is a Swiss biotech company.

TargImmune is developing a novel cancer-targeted platform.

The Tech Park Basel provides spin-offs and early-stage technology-oriented start-ups.

TECregen is a biotechnology company

Resistance-preventing precision therapies to patients with cancer.

VAXIMM developing oral T-cell immunotherapies for patients suffering from cancer.

Versameb is a Swiss based biotechnology platform company